Stocklytics Platform

Score (Market)

publish
The Stocklytics Scoring system delivers a well-rounded evaluation, helping investors identify stocks that excel in critical areas. Whether you're focused on value investing, dividend income, or growth potential, our ranking system gives you the clarity needed to make informed investment decisions.
name
arrow_downwardScore languageValue languageQuality languageOwnership languageGrowth languageDividends languagePrice % Change
Asset logo for symbol XELB
XELBXcel Brands
$0.74arrow_drop_down1.33%AI Analysis
Asset logo for symbol AXL
AXLAmerican Axle & Manufacturing Holdings
$6.37arrow_drop_up3.07%AI Analysis
Asset logo for symbol GKOS
GKOSGlaukos
$128.28arrow_drop_up0.62%AI Analysis
Asset logo for symbol EVRI
EVRIEveri Holdings
$13.14arrow_drop_up0.07%AI Analysis
Asset logo for symbol ASLE
ASLEAerSale Corporation
$5.09arrow_drop_down0.39%AI Analysis
Asset logo for symbol AMED
AMEDAmedisys
$96.60arrow_drop_down0.57%AI Analysis
Asset logo for symbol RBOT
RBOTVicarious Surgical
$5.78arrow_drop_up6.05%AI Analysis
Asset logo for symbol DLTR
DLTRDollar Tree
$73.13arrow_drop_up0.34%AI Analysis
Asset logo for symbol IMTX
IMTXImmatics N.V.
$11.730.00%AI Analysis
Asset logo for symbol NEOV
NEOVNeoVolta
$3.25arrow_drop_down1.51%AI Analysis
Asset logo for symbol RBKB
RBKBRhinebeck Bancorp
$9.25arrow_drop_down1.28%AI Analysis
Asset logo for symbol SPR
SPRSpirit AeroSystems Holdings
$33.10arrow_drop_up0.06%AI Analysis
Asset logo for symbol BATL
BATLBattalion Oil
$6.71arrow_drop_up0.75%AI Analysis
Asset logo for symbol RMBL
RMBLRumbleON
$4.82arrow_drop_up11.57%AI Analysis
Asset logo for symbol MSTR
MSTRMicroStrategy
$176.36arrow_drop_up6.25%AI Analysis
Asset logo for symbol ARTL
ARTLArtelo Biosciences
$1.09arrow_drop_up0.92%AI Analysis
Asset logo for symbol CMPX
CMPXCompass Therapeutics
$1.88arrow_drop_up3.86%AI Analysis
Asset logo for symbol UDMY
UDMYUdemy
$7.64arrow_drop_down5.96%AI Analysis
Asset logo for symbol XOMAP
XOMAPXOMA Corporation
$26.12arrow_drop_down0.45%AI Analysis
Asset logo for symbol CSR
CSRCenterspace
$71.58arrow_drop_down0.63%AI Analysis
Showing 3621-3640 of 4976
Results per page:

When making investment decisions, a holistic view is essential. The Stocklytics Score provides just that—ranking stocks based on five key factors to give you a comprehensive evaluation. With our Market Score, stocks are ordered by our proprietary scoring system, so you can quickly identify top opportunities. The Stocklytics Score is a powerful combination of: - Value Scoring – Find stocks that offer the best value based on fundamental metrics like price-to-earnings and price-to-sales ratios. - Quality Scoring – Invest with confidence by identifying high-quality companies with strong financials and consistent performance. - Ownership Scoring – Analyze institutional and insider ownership to get a sense of the confidence level from key stakeholders. - Growth Scoring – Discover companies with the potential for above-average earnings and revenue growth. - Dividends Scoring – Focus on stocks with strong dividend yields and sustainable payout ratios for long-term income generation. The Stocklytics Scoring system delivers a well-rounded evaluation, helping investors identify stocks that excel in critical areas. Whether you're focused on value investing, dividend income, or growth potential, our ranking system gives you the clarity needed to make informed investment decisions. Why Use the Stocklytics Score? - Comprehensive View: Assess multiple factors at once to get a balanced perspective. - Data-Driven: Rely on a scoring system built from reliable financial data and market insights. - Actionable Rankings: Prioritize stocks based on their overall score or by individual factors like value or growth.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level